Post

(2/3) Canadian researchers have advanced stem cell–derived islet cells and implantable devices, now being tested in clinical trials, that aim to restore natural insulin production, improve cell survival, and reduce the need for daily insulin injections.

0 reposts0 likes

(3/3) SCN has supported this work every step of the way. From 2016–2028, SCN has committed over $11.5 million in funding for innovative diabetes research and clinical trials. ✨ Meet the SCN-funded researchers are helping pave the way.